SERPINB2 Human

Serpin Peptidase Inhibitor, Clade B Member 2 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Biological Functions

Key roles of SERPINB2 include:

FunctionMechanismReferences
Protease InhibitionInhibits uPA and tPA, regulating plasminogen activation and extracellular matrix remodeling.
Immune RegulationPromotes Th2-biased immune responses, monocyte recruitment, and nematode clearance via CCL2 production.
Cell MigrationInhibits uPA-mediated plasmin generation in macrophages, reducing migration speed.
Apoptosis ModulationProtects retinoblastoma protein (RB1) from calpain digestion, delaying TNF-α-induced apoptosis.
Toxicity ResponseActs as a biomarker for stem cell toxicity, linked to apoptosis and reduced differentiation.

Role in Macrophage Biology

  • SerpinB2 is constitutively expressed in large peritoneal macrophages (LPM) and inhibits migration by counteracting plasmin activity .

  • RNA-Seq analysis revealed SerpinB2 suppresses Gata6-regulated genes involved in extracellular matrix interactions .

Stem Cell Toxicity and Differentiation

  • SERPINB2 overexpression in stem cells reduces proliferation (5.08–10.13% apoptosis rate), migration (via MMP-2 suppression), and differentiation potential .

  • Conversely, SERPINB2 knockdown enhances osteoblast/adipocyte differentiation and migration .

Clinical and Diagnostic Relevance

  • Elevated SERPINB2 correlates with toxicity in human stem cells exposed to dioxins, UV irradiation, and chemotherapeutics .

  • Integrated into oral-on-a-chip systems for rapid toxicity screening via GFP-tagged detection .

Production and Applications

Recombinant SERPINB2 (e.g., His-tagged 49 kDa protein produced in E. coli) is used for studying protease inhibition and immune modulation . Its roles in cancer (e.g., promoting tumor survival) and neurodegenerative diseases (e.g., inhibiting β-amyloid fibril formation) are under investigation .

Product Specs

Introduction

SERPINB2, primarily found in keratinocytes, stimulated monocytes, and placental trophoblasts, is an inhibitory serpin. It exists mainly as a 47 kDa intracellular protein that is not glycosylated. Upon induction, it is secreted as a 60 kDa glycoprotein. Both forms effectively inhibit uPA, the only confirmed physiological target of SERPINB2.

Description
Recombinant human SERPINB2, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 415 amino acids. It has a molecular weight of 46.6 kDa.
The purification of SERPINB2 is carried out using proprietary chromatographic methods.
Physical Appearance
The product appears as a sterile, filtered, white lyophilized (freeze-dried) powder.
Formulation
The product is lyophilized from a 0.2µm filtered concentrated solution in 20mM Tris-HCl (pH 8.0), 150mM NaCl, 1mM Cysteine, and 5% Trehalose.
Solubility

To reconstitute the lyophilized SERPINB2, it is recommended to dissolve it in sterile 18MΩ-cm H2O at a concentration not less than 100µg/ml. This solution can be further diluted in other aqueous solutions.

Stability
Lyophilized SERPINB2 remains stable at room temperature for up to 3 weeks. However, for extended storage, it is recommended to store it desiccated at temperatures below -18°C. After reconstitution, SERPINB2 should be stored at 4°C for 2-7 days. For long-term storage, adding a carrier protein like 0.1% HSA or BSA is recommended. It is crucial to avoid repeated freeze-thaw cycles to maintain product stability.
Purity
The purity of the product is determined using the following methods and is found to be greater than 97.0%:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Biological Activity
The biological activity is assessed based on the product's ability to inhibit single-chain tPA-induced cleavage of a chromogenic substrate in Imidazole Buffer at 37°C. The half-maximal inhibition against 1.0 µg/ml of single-chain tPA was observed at a product concentration of 1.0µg/ml.
Synonyms

Serpin Peptidase Inhibitor Clade B (Ovalbumin) Member 2, Serine (Or Cysteine) Proteinase Inhibitor Clade B (Ovalbumin) Member 2, Placental Plasminogen Activator Inhibitor, Plasminogen Activator Inhibitor Type II (Arginine-Serpin), PAI2, PLANH2, Monocyte Arg-Serpin, Serpin B2, HsT1201, PAI.

Source
Escherichia Coli.
Amino Acid Sequence
MEDLCVANTL FALNLFKHLA KASPTQNLFL SPWSISSTMA MVYMGSRGST EDQMAKVLQF NEVGANAVTP MTPENFTSCG FMQQIQKGSY PDAILQAQAA DKIHSSFRSL SSAINASTGN YLLESVNKLF GEKSASFREE YIRLCQKYYS SEPQAVDFLE CAEEARKKIN SWVKTQTKGK IPNLLPEGSV DGDTRMVLVN AVYFKGKWKT PFEKKLNGLY PFRVNSAQRT PVQMMYLREK LNIGYIEDLK AQILELPYAG DVSMFLLLPD EIADVSTGLE LLESEITYDK LNKWTSKDKM AEDEVEVYIP QFKLEEHYEL RSILRSMGME DAFNKGRANF SGMSERNDLF LSEVFHQAMV DVNEEGTEAA AGTGGVMTGR TGHGGPQFVA DHPFLFLIMH KITNCILFFG RFSSP 

Q&A

What is SERPINB2 and what cellular processes does it regulate?

SERPINB2 (Serpin Family B Member 2) is a member of the serine protease inhibitor family that functions as a plasminogen activator inhibitor (PAI-2) . It is one of the most highly inducible genes in monocytes and can constitute up to 1% of total cellular protein during inflammatory responses . Recent functional analyses have revealed that a key role of SERPINB2 is modulating proteotoxic stress . Additionally, it regulates cell proliferation, differentiation, and plays important roles in innate immunity and macrophage survival .

The protein structure follows the conserved SERPIN pattern with a globular domain containing critical central beta sheets and a reactive center loop (RCL) that protrudes from the main SERPIN body . This structure is essential for its protease inhibition mechanism and subsequent biological functions.

In which cell types and tissues is SERPINB2 expressed?

SERPINB2 exhibits tissue-specific and condition-dependent expression patterns:

Cell/Tissue TypeExpression LevelConditionsReference
MonocytesUp to 1% of total cellular proteinInflammatory states
KeratinocytesHighNormal and inflammatory conditions
PlacentaModerateNormal physiological conditions
AdipocytesModerateNormal physiological conditions
Airway epithelial cellsLow in healthy, high in COVID-19 patientsDisease-specific upregulation
MacrophagesHigh upon stimulationLPS and inflammatory stimuli

This expression profile suggests SERPINB2 plays multiple tissue-specific roles, with particularly important functions in immune cells during inflammatory responses .

How is SERPINB2 expression experimentally measured in research settings?

For comprehensive evaluation of SERPINB2 expression, researchers employ multiple complementary techniques:

TechniqueMeasurementApplicationMethodological ConsiderationsReference
qPCRmRNA levelsExpression analysisPrimer design must accommodate transcript variants
Western blottingProtein levelsExpression analysisAntibody specificity critical for accurate detection
ChIP-seqHistone modifications at promoterEpigenetic regulationRequires cross-linking optimization
Reporter constructsPromoter activityPromoter mapping5'-flanking region constructs used for deletion analysis
Single-cell RNA-seqCell-specific expressionHeterogeneity analysisRequires high-quality single-cell isolation
EMSAProtein-DNA interactionsTranscription factor bindingNuclear extract preparation quality is crucial

To map LPS-regulated SERPINB2 promoter regions, researchers have successfully used reporter constructs driven by the ~5 kb 5'-flanking region of the murine SERPINB2 gene with several deletion mutants transfected into murine macrophages .

How is SERPINB2 dysregulated in inflammatory diseases?

SERPINB2 shows significant dysregulation in multiple inflammatory conditions:

DiseaseSERPINB2 StatusEpigenetic ChangesFunctional ImplicationsReference
Inflammatory Bowel DiseaseMost highly upregulated geneNot fully characterizedPotential biomarker and therapeutic target
Systemic Lupus ErythematosusStrongly upregulatedIncreased H3K4me3 at promoterCorrelates with disease activity
Type III AngioedemaImplicatedNot fully characterizedMechanistic role under investigation
COVID-19Upregulated in epithelial cellsCorrelates with interferon-stimulated genesPotential role in antiviral response

ChIP-seq data on SLE patients demonstrated higher H3K4me3 (a histone modification associated with active transcription) both downstream and upstream of the SERPINB2 transcription start site, corresponding with higher SERPINB2 mRNA levels in these patients . This epigenetic signature suggests chromatin remodeling contributes to SERPINB2 dysregulation in inflammatory diseases.

What is SERPINB2's role in stem cell toxicity and how can this be experimentally assessed?

SERPINB2 serves as a novel indicator of stem cell toxicity, with expression significantly increased in response to various toxic agents both in vitro and in vivo . When SERPINB2 expression is enhanced in stem cells, these functional effects are observed:

EffectExperimental MeasurementObserved ChangeMethodological ApproachReference
Self-renewal capacityColony formation assaySignificantly reducedSerial colony-forming unit assays
Migration abilityTranswell migration assaySignificantly reducedBoyden chamber assays
Multi-lineage differentiationLineage-specific inductionImpairedDifferentiation into multiple cell types
ApoptosisFlow cytometrySignificantly inducedAnnexin V/PI staining

Researchers have noted that different toxic substances elicit varying degrees of SERPINB2 induction:

Toxic Response CategorySERPINB2 Expression LevelProportion of Tested SubstancesDetection MethodReference
Significantly enhanced>5-fold increase3 out of 10 testedqPCR/Western blot
Moderately increased2-5 fold increase3 out of 10 testedqPCR/Western blot
Minimally increased<2-fold increase4 out of 10 testedqPCR/Western blot

These observations suggest SERPINB2 could serve as a sensitive biomarker for toxicity screening, particularly for human stem cell-based in vitro toxicity assessment platforms .

How does SERPINB2 expression correlate with cancer progression?

SERPINB2 expression has been associated with tumor promotion and poor prognosis in multiple cancer types:

Cancer TypeSERPINB2 StatusClinical CorrelationProposed MechanismReference
Bladder cancerUpregulatedPoor prognosisCell growth regulation disruption
Colorectal cancerAssociated with tumor promotionPoor survivalAltered differentiation potential
Endometrial cancerUpregulatedTumor promotionNot fully characterized
Ovarian cancerAssociated with tumor progressionPoor outcomesNot fully characterized

Understanding the dual role of SERPINB2 in both suppressing cell growth and being associated with poor prognosis in certain cancers represents an important research paradox requiring further investigation into context-dependent functions .

What transcription factors and upstream signals regulate SERPINB2 expression?

Multiple transcription factors and signaling pathways regulate SERPINB2 expression:

Regulatory FactorContextMechanismExperimental EvidenceReference
NFκBInflammatory stimuliDirect promoter bindingEMSA, reporter assays
AP-1Inflammatory stimuliTwo response elements in proximal promoterMutation analysis, EMSA
C/EBPβLPS stimulationCCAAT enhancer binding element interactionChIP, EMSA, knockout studies
STAT6Th2 responsesCytokine-induced activationNot fully characterized
cAMP response elementLPS inductionCRE in proximal promoterMutation analysis

Experimental evidence from C/EBP-β-null mouse embryonic fibroblasts (MEFs) and primary C/EBP-β-deficient peritoneal macrophages shows severely abrogated SERPINB2 expression in both constitutive and LPS-induced conditions, demonstrating the critical importance of C/EBP-β in SERPINB2 regulation .

What are the key promoter elements controlling SERPINB2 expression?

Mutation analyses have identified several critical regulatory elements in the SERPINB2 promoter:

Promoter ElementPositionFunctionEffect of MutationExperimental ApproachReference
CCAAT enhancer binding (C/EBP) elementProximal promoterLPS response mediationSeverely reduced inducibilityReporter constructs with deletion mutants
Cyclic AMP response element (CRE)Proximal promoterLPS-inducibilityReduced promoter activitySite-directed mutagenesis
AP-1 response elements (2)Proximal promoterInflammatory responseImpaired LPS responseReporter assays with mutated sites

These elements work in concert to achieve the high inducibility of SERPINB2 in response to inflammatory stimuli, particularly LPS . Researchers mapped these elements by transfecting reporter constructs driven by the ~5 kb 5'-flanking region of the murine SERPINB2 gene and several deletion mutants into murine macrophages .

What epigenetic mechanisms control SERPINB2 expression?

Epigenetic regulation plays a critical role in SERPINB2 expression, particularly in disease states:

Epigenetic MechanismEffect on SERPINB2ContextDetection MethodReference
Histone acetylationModulation of expressionGeneral regulationHDAC inhibitor studies
H3K4me3 modificationIncreased at promoter in SLEDisease-specific upregulationChIP-seq
Chromatin remodelingAltered accessibility in inflammationInflammatory conditionsNot fully characterized

Investigation of epigenetic regulation is critical given the aberrant expression of SERPINB2 in many human disease states and its highly dynamic expression patterns . ChIP-seq data has revealed higher H3K4me3 both downstream and upstream of the transcription start site in SLE patients, corresponding with increased mRNA levels .

What cellular and animal models are optimal for studying SERPINB2 functions?

Various models have been used to study different aspects of SERPINB2 regulation and function:

ModelApplicationAdvantagesLimitationsKey FindingsReference
Human UCB-derived stem cellsToxicity studiesPhysiologically relevantDonor variabilitySERPINB2 as toxicity marker
Mouse embryonic fibroblasts (MEFs)Transcription factor studiesGenetic manipulationNot immune cellsC/EBP-β dependency
C/EBP-β-deficient peritoneal macrophagesInflammation studiesPrimary immune cellsLimited lifespanAbrogated SERPINB2 expression
Human stem cell-based platformsToxicity screeningHigh sensitivityComplex culture requirementsMultiple toxic substance detection
Bronchoalveolar lavage fluid cells (BALF)Disease-specific expressionDirect patient samplesComplex cell mixtureCOVID-19 upregulation

When selecting models, researchers should consider the specific aspect of SERPINB2 biology being investigated. For inflammatory regulation, macrophage models are preferable, while toxicity studies benefit from stem cell models .

How can protein-protein interactions between SERPINB2 and target proteases be studied?

Understanding SERPINB2's interactions with proteases requires specialized techniques:

MethodApplicationTechnical ConsiderationsOutputReference
Protein-protein docking screensPredict SERPIN-protease pairsStructure-based computational approachBinding energy predictions
Analysis of RCL fit to protease active siteInteraction predictionRequires structural dataSteric compatibility assessment
Biochemical inhibition assaysFunctional verificationPurified proteins neededKinetic inhibition parameters
Pull-down assaysPhysical interactionAntibody specificity criticalComplex formation detection

Protein-protein docking screens based on structure have proven valuable for identifying novel SERPIN-protease pairs, specifically by predicting the fit of the SERPIN reactive center loop (RCL) into the protease active site .

What approaches best reveal SERPINB2's role in inflammatory responses?

To investigate SERPINB2's role in inflammation, researchers employ multiple complementary approaches:

ApproachApplicationExperimental SetupKey ReadoutsReference
LPS stimulationAcute inflammatory responseTime-course experimentsExpression kinetics
Gene knockout/knockdownLoss-of-functionCRISPR, siRNA, or genetic modelsPathway alterations
ChIP assaysTranscription factor bindingC/EBP-β antibodiesPromoter occupancy
Patient sample analysisDisease relevanceSLE, IBD, COVID-19 samplesExpression correlation with disease markers
Single-cell RNA-seqCellular heterogeneityBALF from COVID-19 patientsCell-specific expression patterns

For example, researchers have demonstrated that LPS induces the formation of C/EBP-β containing complexes with the SERPINB2 promoter using electrophoretic mobility shift (EMSA) and chromatin immunoprecipitation (ChIP) assays , providing mechanistic insight into inflammatory regulation.

How might SERPINB2 be exploited as a biomarker for toxicity prediction?

SERPINB2 shows promise as a biomarker for toxicity prediction in stem cell-based platforms:

ApplicationCurrent EvidenceImplementation ApproachChallengesReference
Universal toxicity markerResponds to 6/10 toxic substancesqPCR detection after exposureVariable sensitivity
Stem cell-specific toxicityEnhanced expression in UCB-derived stem cellsIn vitro screening platformStandardization needed
Industrialization toxicity screeningProof-of-concept demonstratedCombined with other markersValidation with larger compound sets
Mechanism-based screeningLinks to cell proliferation and differentiationFunctional readouts with SERPINB2 as markerMechanistic understanding incomplete

Researchers found that SERPINB2 expression is significantly increased in response to multiple "danger" signals, including bacterial lipopolysaccharide, hypoxia, and cytotoxic agents . By combining SERPINB2 expression analysis with stem cell models, researchers can develop sensitive screening platforms that provide valuable information on toxic compounds not normally detected by other somatic cell-based systems .

What unexplored antiviral functions might SERPINB2 possess?

SERPINB2's potential antiviral functions represent an emerging research area:

Antiviral AspectPreliminary EvidenceResearch ApproachPotential ImpactReference
Protease inhibitionSERPIN mechanism of actionDocking screens with viral proteasesNovel antiviral strategies
Correlation with interferon responseExpression pattern in COVID-19Single-cell transcriptomicsBiomarker for antiviral response
Respiratory virus defenseUpregulation in airway epithelial cellsIn vitro infection modelsUnderstanding pathogenesis
Inflammatory modulationAssociation with TNF and IFN pathwaysPathway analysisTreatment target identification

Analysis of bronchoalveolar lavage fluids (BALF) from COVID-19 patients revealed that SERPINB2 is one of several SERPINs upregulated in epithelial cells during infection . Correlation analysis showed that SERPINB2 expression levels correlate with those of canonical TNF-alpha and interferon-stimulated genes, suggesting participation in viral-induced inflammation responses .

How do contradictory findings regarding SERPINB2 in cell growth regulation reconcile in different contexts?

SERPINB2 exhibits context-dependent effects that require nuanced investigation:

ContextSERPINB2 EffectApparent ContradictionReconciliation ApproachReference
Stem cellsSuppresses self-renewal and growthEnhanced expression can induce apoptosisOverexpression vs. physiological levels
Cancer cellsAssociated with tumor promotionShould inhibit growth based on stem cell dataCell-type specific pathways investigation
Toxicant exposureIncreased expressionDioxin increases SERPINB2 but doesn't induce apoptosisDifferential expression levels and co-factors
Inflammatory conditionsHighly upregulatedFunctional significance varies by diseaseDisease-specific pathway analysis

The contrasting effects of SERPINB2 overexpression versus dioxin-induced expression highlight an important research consideration: SERPINB2 overexpression significantly induces apoptosis in human stem cells, but dioxin treatment, while increasing SERPINB2, does not induce apoptosis . This discrepancy likely results from differences in SERPINB2 expression levels and accompanying cellular context changes . Resolving such contradictions requires careful experimental design accounting for expression levels, cellular context, and interaction partners.

What aspects of SERPINB2 regulation remain poorly understood?

Despite significant progress, several aspects of SERPINB2 regulation remain unexplored:

Knowledge GapCurrent UnderstandingResearch OpportunityMethodological ApproachReference
Complete epigenetic landscapeSome histone modifications identifiedComprehensive epigenome mappingChIP-seq, ATAC-seq, DNA methylation analysis
Tissue-specific regulatory elementsProximal promoter characterizedEnhancer identificationChromatin conformation capture (3C/4C/Hi-C)
Post-transcriptional regulationLimited knowledgemiRNA and RNA-binding protein interactionsCLIP-seq, RNA stability assays
Signaling pathway integrationSome pathways identifiedSystems biology approachPhosphoproteomics, pathway perturbation

The epigenetic control of SERPINB2 expression has not been previously extensively investigated despite its aberrant expression in many human disease states and highly dynamic expression patterns . This represents a significant knowledge gap that could be addressed through comprehensive epigenetic profiling.

What methodological limitations constrain current SERPINB2 research?

Current research faces several methodological challenges:

LimitationImpact on ResearchPotential SolutionImplementation ConsiderationReference
Cellular heterogeneityDiluted signal in mixed populationsSingle-cell approachesCost and computational complexity
Limited structural dataIncomplete understanding of interactionsCryo-EM and structural biologyTechnical expertise required
Lack of standardized modelsDifficult cross-study comparisonModel standardization initiativesCollaboration between research groups
Translation to in vivo relevanceIn vitro/in silico limitationsImproved animal modelsEthical and practical constraints

The cellular heterogeneity challenge is particularly evident in studies of SERPINB2 in complex tissues. Single-cell RNA-seq of bronchoalveolar lavage fluids from COVID-19 patients has begun to address this by allowing investigation of mRNA expression levels of individual SERPINs in different cell types at the site of infection .

How might emerging technologies advance SERPINB2 research?

Emerging technologies offer new opportunities for SERPINB2 investigation:

TechnologyApplication to SERPINB2 ResearchPotential ImpactImplementation TimelineReference
Spatial transcriptomicsTissue-specific expression patternsDisease context understandingNear-term application
CRISPR-based epigenome editingCausal testing of epigenetic regulationMechanistic insightsMid-term application
AI-driven protein structure predictionEnhanced protease interaction modelingNew target identificationCurrently applicable
Organoid modelsDisease-specific regulationPhysiologically relevant insightsCurrently applicable

For instance, protein-protein docking screens enabled by improved computational methods have already identified novel SERPIN-protease pairs based on structure . These approaches are particularly valuable for understanding SERPINB2's potential role in antiviral responses by predicting interaction with proteases involved in viral replication cycles.

Product Science Overview

Gene and Protein Structure

The SERPINB2 gene is located on chromosome 18 in humans and encodes a protein that is primarily found as a 47 kDa non-glycosylated intracellular protein. Upon induction, it can be secreted as a 60 kDa glycoprotein . The glycosylated and non-glycosylated forms of SERPINB2 are similarly effective as inhibitors of urokinase-type plasminogen activator (uPA), which is the only proven physiological target of SERPINB2 .

Function and Mechanism

SERPINB2 functions as an inhibitor of uPA, a serine protease involved in the degradation of the extracellular matrix and the activation of other proteases. By inhibiting uPA, SERPINB2 plays a crucial role in regulating processes such as tissue remodeling, cell migration, and inflammation . The inhibition mechanism involves the formation of a stable complex between SERPINB2 and uPA, which prevents uPA from interacting with its substrates .

Biological Significance

SERPINB2 is involved in various physiological and pathological processes. It is expressed in a variety of tissues, including the placenta, monocytes, and macrophages. Its expression is upregulated in response to inflammatory stimuli, indicating its role in the immune response . Additionally, SERPINB2 has been implicated in several diseases, including gingivitis and pre-eclampsia .

Recombinant Production

Recombinant SERPINB2 is produced using various expression systems, such as E. coli, to facilitate its study and potential therapeutic applications. The recombinant protein retains the functional properties of the native protein, making it a valuable tool for research and drug development .

Clinical and Research Applications

Due to its role in inhibiting uPA, SERPINB2 is of interest in cancer research, particularly in the context of tumor invasion and metastasis. By modulating the activity of uPA, SERPINB2 can potentially influence the invasive properties of cancer cells . Furthermore, its involvement in inflammatory responses makes it a target for studying inflammatory diseases and developing anti-inflammatory therapies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.